Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
A mandibular advancement device (MAD) is a removable oral appliance worn during sleep that holds the lower jaw (mandible) in a repositioned, forward posture. In US regulation it is called a mandibular repositioning device and is classified as a Class II medical device. This guide is for clinic staff, buyers and students who need to know what the product class is, how FDA defines it, and what the agency expects its labeling and materials documentation to say.
This page describes products and general use; it is not medical advice.
What is a mandibular advancement device?
A mandibular advancement device is an intraoral device for snoring and obstructive sleep apnea. 21 CFR 872.5570 identifies these devices as devices worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea, and lists mandibular repositioning devices among them. FDA describes the whole class as removable medical devices that are fitted in the patient’s mouth. The name describes the function: the appliance repositions the mandible, and FDA states the shared goal of the class as increasing the pharyngeal space to improve the patient’s ability to exchange air.
Who uses it: dentists and other clinicians who prescribe and fit oral appliances, and the patients who wear them. Buyers and clinic staff meet the product class in dental and sleep-medicine supply.
How is a mandibular advancement device regulated in the United States?
Under 21 CFR 872.5570 (“Intraoral devices for snoring and obstructive sleep apnea”), these devices are Class II, with FDA’s class II special controls guidance as the special control. FDA lists two product codes for the generic type: LQZ (Jaw Repositioning Device) and LRK (Anti-Snoring Device). The FDA guidance also states that these devices are prescription devices unless adequate directions for use (21 CFR 801.5) are developed and FDA clears a 510(k) specifically for over-the-counter distribution. The guidance does not cover implantable screw devices used in surgery; those are excluded from this classification.
For background on how clearance works, see the CASRAI guides on the FDA 510(k) and De Novo submission template and the dictionary entry for the Medical Device Amendments of 1976.
How is it built? Materials and construction
FDA’s special controls guidance does not prescribe one design or one material. It asks manufacturers to document material identity and complete chemical composition (or declare conformance to a materials standard), to supply safety data sheets for all materials used, and to show biocompatibility for a surface device with prolonged contact with intraoral (mucosal, gingival and palatal) surfaces with testing described in Parts 5 and 10 of ISO 10993. If a device contains a thermal setting resin, the labeling must include instructions for heating, cooling and setting time.
Types and variants
FDA recognizes three basic designs of intraoral device for snoring and obstructive sleep apnea. A mandibular advancement device falls in the first row.
| Design (FDA term) | Named in 21 CFR 872.5570 | Key point |
|---|---|---|
| Mandibular repositioner (mandibular advancement device) | Yes, as mandibular repositioning devices | Repositions the lower jaw; the subject of this page |
| Tongue retaining device | Yes | A separate design; FDA lists it alongside the other two |
| Palatal lifting device | Yes | A separate design; FDA lists it alongside the other two |
FDA states that all three designs provide the same therapeutic goal of increasing the pharyngeal space. Implantable screw devices are not part of this classification.
What documentation a buyer can ask a supplier for
The FDA guidance defines what documentation should exist for a device in this class, which a clinic can ask a supplier about:
- Regulatory status: whether the device is cleared under 21 CFR 872.5570, and whether it is a prescription device or has an over-the-counter 510(k).
- Materials: identity and chemical composition of the materials, with safety data sheets.
- Biocompatibility: testing for prolonged intraoral surface contact under ISO 10993.
- Labeling: contraindications, warnings and complete use and care instructions for the patient, plus heating, cooling and setting instructions where a thermal setting resin is used.
Safe use and handling basics
FDA’s labeling section lists the following for this device class. These are product labeling statements, not individual advice.
| Category | What FDA says the labeling should include |
|---|---|
| Contraindications | Central sleep apnea; severe respiratory disorders; loose teeth or advanced periodontal disease; under 18 years of age |
| Warnings | Tooth movement or changes in dental occlusion; gingival or dental soreness; pain or soreness of the temporomandibular joint; obstruction of oral breathing; excessive salivation |
| Patient labeling | Clear, accurate use and care instructions |
The related CASRAI guide What is a CPAP machine? covers another device class used in sleep apnea care, and adverse events with cleared devices can be reported through medical device reporting.
Common mistakes
- Treating every anti-snoring product as the same class. FDA separates mandibular repositioners, tongue retaining devices and palatal lifting devices.
- Assuming an over-the-counter sale. The guidance treats these devices as prescription devices unless an OTC-specific 510(k) has been cleared.
- Overlooking the contraindications and warnings in a product’s labeling when reviewing it.
- Ignoring the materials file. Material identity, safety data sheets and ISO 10993 biocompatibility testing are part of what FDA expects for intraoral contact.
Frequently asked questions
What is a mandibular advancement device?
It is a removable intraoral device worn during sleep that repositions the lower jaw; FDA classifies it as a mandibular repositioning device for snoring and obstructive sleep apnea under 21 CFR 872.5570.
Is a mandibular advancement device a medical device?
Yes. It is a Class II medical device under 21 CFR 872.5570, with FDA’s class II special controls guidance as the special control.
Does it need a prescription?
FDA’s guidance says intraoral devices for snoring and obstructive sleep apnea are prescription devices unless adequate directions for use are developed and FDA clears a 510(k) specifically for over-the-counter distribution.
What does FDA say the labeling for this device class should contain?
FDA’s guidance lists contraindications, warnings, complete use and care instructions for the patient, and heating, cooling and setting-time instructions where a thermal setting resin is used.
Sources
- 21 CFR 872.5570, Intraoral devices for snoring and obstructive sleep apnea, checked 2026-10-31: law.cornell.edu/cfr/text/21/872.5570 (also published on eCFR).
- FDA, Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea, checked 2026-10-31: fda.gov guidance page.







